Barometer Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-15,200
Closed -$463K – 147
2025
Q4
$463K Buy
15,200
+11,877
+357% +$554K 0.11% 109
2025
Q3
$143K Hold
3,323
– – 0.03% 160
2025
Q2
$128K Hold
3,323
– – 0.04% 169
2025
Q1
$129K Hold
3,323
– – 0.05% 133
2024
Q4
$128K Hold
3,323
– – 0.05% 126
2024
Q3
$136K Hold
3,323
– – 0.04% 144
2024
Q2
$128K Sell
3,323
-4,900
-60% -$206K 0.05% 158
2024
Q1
$341K Buy
8,223
+5,023
+157% +$207K 0.09% 124
2023
Q4
$119K Buy
+3,200
New +$115K 0.03% 148

Other funds holding GSK

Barometer Capital Management's GSK Position: Q1 2026 in Review

Barometer Capital Management sold out of GSK (GSK) in Q1 2026, closing a stake of 15,200 shares — an estimated $463K sold.

Barometer Capital Management first reported a position in GSK in Q4 2023 and held it in 9 quarters. The position peaked at $463K in Q4 2025. 1,038 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Barometer Capital Management reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Barometer Capital Management sold 15,200 GSK shares in Q1 2026, an estimated $463K.
  • Barometer Capital Management first reported a position in GSK in Q4 2023 and held it in 9 quarters.
  • Barometer Capital Management's GSK position peaked at $463K in Q4 2025.
  • 1,038 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Barometer Capital Management's 13F filing for Q1 2026, filed 12 May 2026.